Novedades

• Five Chinese companies join UN’s MPP for Covid-19 medicines
• South Korean companies to make generic Bridion and COVID-19 drugs
• Revlimid (lenalidomide) generics launch across Europe
• Cancer and diabetes generic treatments receive positive opinion from EMA’s CHMP

Investigación

• What is the meaning of a narrow therapeutic index?
• Consequences of generics being favoured by healthcare providers
• What is meant by a generic medication and generic equivalence?
• The cost of developing drugs and use of generics

General

• Empresas farmacéuticas en América Latina y el Caribe
• Canada calls for support to national pharmacare and generics industry
• UK NHS faces drug shortages
• High drug bills? Turn to your pharmacist for help

Novedades

• FDA approves pegfilgrastim and rituximab biosimilars
• Byooviz: first ophthalmology biosimilar launches in US
• Biocon: cancer biosimilar launch in Canada and US$90 million Malaysia deal
• Canada approves five biosimilars in last seven months

Investigación

• No trends in biosimilars uptake levels in the US, reveals study
• El impacto de las insulinas biosimilares en el gasto público brasileño
• Challenges with implementing benefit-sharing programmes for biologicals in Europe
• Successful increase of biosimilar adoption in a large integrated health delivery network

General

• Estado actual de los biosimilares de anticuerpos monoclonales aprobados en América Latina
• Una visión general de los biosimilares de anticuerpos monoclonales en América Latina
• American Academy of Ophthalmology biosimilars position statement published
• US prescription drug expenditure projection report

• Latin American Forum
• Fármacos complejos no biológicos
• Enfoque por país

• Directrices
• Políticas y legislación
• Informes

• Congresos
• Artículos patrocinados
• Enlaces patrocinados